Overview

A Study of HS-10518 in Healthy Adult Premenopausal Females in China

Status:
COMPLETED
Trial end date:
2025-09-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HS-10518 in healthy adult premenopausal females in China
Phase:
PHASE1
Details
Lead Sponsor:
West China Second University Hospital
Collaborator:
Jiangsu Hansoh Pharmaceutical Co., Ltd.